I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 13 studies | 22% ± 7% | |
| fibroblast | 10 studies | 22% ± 6% | |
| natural killer cell | 6 studies | 18% ± 2% | |
| B cell | 5 studies | 18% ± 2% | |
| pericyte | 5 studies | 20% ± 3% | |
| CD8-positive, alpha-beta T cell | 5 studies | 17% ± 2% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 19% ± 3% | |
| CD4-positive, alpha-beta T cell | 4 studies | 18% ± 3% | |
| myofibroblast cell | 4 studies | 18% ± 4% | |
| epithelial cell | 4 studies | 38% ± 16% | |
| capillary endothelial cell | 4 studies | 17% ± 2% | |
| endothelial cell of vascular tree | 4 studies | 17% ± 2% | |
| gamma-delta T cell | 4 studies | 24% ± 11% | |
| basal cell | 4 studies | 23% ± 4% | |
| T cell | 3 studies | 19% ± 1% | |
| pancreatic A cell | 3 studies | 23% ± 7% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 17% ± 2% | |
| smooth muscle cell | 3 studies | 19% ± 1% | |
| abnormal cell | 3 studies | 18% ± 2% | |
| endothelial cell of artery | 3 studies | 17% ± 1% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 20% ± 2% | |
| mucosal invariant T cell | 3 studies | 17% ± 1% | |
| naive B cell | 3 studies | 17% ± 1% | |
| connective tissue cell | 3 studies | 20% ± 2% |
